[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 50, "title": "Co-Founder, CEO & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 570781, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 67, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 61, "title": "Co-Founder, Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nilay  Patel J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Downey Bryan Wade", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.34, "open": 4.31, "dayLow": 4.26, "dayHigh": 4.4, "regularMarketPreviousClose": 4.34, "regularMarketOpen": 4.31, "regularMarketDayLow": 4.26, "regularMarketDayHigh": 4.4, "payoutRatio": 0.0, "beta": -0.751, "forwardPE": -3.106383, "volume": 121666, "regularMarketVolume": 121666, "averageVolume": 173793, "averageVolume10days": 118890, "averageDailyVolume10Day": 118890, "bid": 2.88, "ask": 5.03, "bidSize": 2, "askSize": 2, "marketCap": 29595968, "fiftyTwoWeekLow": 3.2, "fiftyTwoWeekHigh": 6.01, "allTimeHigh": 1236.0, "allTimeLow": 1.8, "fiftyDayAverage": 3.8046, "twoHundredDayAverage": 4.08835, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28056066, "profitMargins": 0.0, "floatShares": 6749232, "sharesOutstanding": 6757070, "sharesShort": 347249, "sharesShortPriorMonth": 258537, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0514, "heldPercentInsiders": 0.015039999, "heldPercentInstitutions": 0.043709997, "shortRatio": 2.81, "shortPercentOfFloat": 0.052399997, "impliedSharesOutstanding": 6757070, "bookValue": 0.581, "priceToBook": 7.538727, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -21394232, "trailingEps": -2.77, "forwardEps": -1.41, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -1.404, "52WeekChange": -0.12676054, "SandP52WeekChange": 0.14561749, "quoteType": "EQUITY", "currentPrice": 4.38, "targetHighPrice": 58.0, "targetLowPrice": 8.0, "targetMeanPrice": 26.47667, "targetMedianPrice": 20.93, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 6118710, "totalCashPerShare": 0.906, "ebitda": -19980968, "totalDebt": 4578809, "quickRatio": 1.046, "currentRatio": 1.264, "debtToEquity": 131.814, "returnOnAssets": -1.06645, "returnOnEquity": -2.7585402, "grossProfits": -12100792, "freeCashflow": -10430769, "operatingCashflow": -17727424, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cingulate Inc.", "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1767388204, "regularMarketTime": 1767387601, "marketState": "CLOSED", "regularMarketChangePercent": 0.921658, "regularMarketPrice": 4.38, "regularMarketDayRange": "4.26 - 4.4", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 173793, "fiftyTwoWeekLowChange": 1.1800001, "fiftyTwoWeekLowChangePercent": 0.36875, "fiftyTwoWeekRange": "3.2 - 6.01", "fiftyTwoWeekHighChange": -1.6300001, "fiftyTwoWeekHighChangePercent": -0.27121466, "fiftyTwoWeekChangePercent": -12.676054, "epsTrailingTwelveMonths": -2.77, "epsForward": -1.41, "epsCurrentYear": -11.825, "priceEpsCurrentYear": -0.3704017, "fiftyDayAverageChange": 0.5754001, "fiftyDayAverageChangePercent": 0.15123801, "twoHundredDayAverageChange": 0.2916503, "twoHundredDayAverageChangePercent": 0.071336925, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "cryptoTradeable": false, "longName": "Cingulate Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "postMarketChangePercent": 0.0, "postMarketPrice": 4.38, "postMarketChange": 0.0, "regularMarketChange": 0.04, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]